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Abstract. A randomized, double-blinded, placebo-controlled study was conducted to examine the effect of spatial 
repellent (SR) in households at risk of malaria in Indonesia. Following presumptive radical cure for malaria in 180 adult men 
representing sentinels of new infection in four clusters within two villages, all households were given either metofluthrin 
or placebo mosquito coils. Weekly blood smear screening and human-landing mosquito catches were done throughout 
the 6 months intervention. Malaria infections occurred in 61 subjects living in placebo households and 31 subjects living 
in SR coil households, suggesting a 52% protective effect of SR. Likewise, anopheles indoor human landing rates were 
32% lower in homes receiving SR coils. Differences in the malaria attack rate between SR- and placebo-treated homes 
was significant when not accounting for the effects of clustering. When the analysis was adjusted for intra-cluster 
correlation, the differences between SR- and placebo-treated homes were not statistically significant. The findings 
provide evidence of SR public health benefit and support a larger trial statistically powered to detect those effects.
INTRODUCTION
Malaria continues to be a significant global public health 
burden despite recent progress in reducing disease rates.1’2 
Currently, the recommended tools for malaria control and 
management from global health authorities, such as the World 
Health Organization (WHO), include diagnosis, chemotherapy, 
indoor residual spraying (IRS), and long-lasting insecticide- 
treated nets (LLINs) to reduce transmission and risk of infec­
tion and illness.3 The effectiveness of these tools depend upon 
many factors such as the quality of diagnostic and treatment 
services, coverage of homes with IRS or LLINS, relative trans­
mission level, and many social and economic factors. Further­
more, the spread of parasite and anopheline vector resistance 
to various antimalarial drugs and insecticides, respectively, in 
combination with the lack of an efficacious malaria vaccine, 
collectively threaten the effectiveness of current malaria control 
efforts. This reality emphasizes the need to develop innovative 
preventive tools that exploit novel mechanisms of action 
against either the anopheline vector or Plasmodium spp. par­
asite. Modifying vector behavior through the chemical action 
of spatial repellency (SR)4 is one such approach. Here, we 
define SR as the ability of airborne chemicals to reduce 
human vector contact by eliciting one or more insect behav­
iors.5 As early as 1953, Muirhead-Thomson6 concluded that 
chemicals could disrupt contact between humans and malaria- 
transmitting mosquitoes and thus stop disease transmission 
without actually killing mosquitoes. Subsequent authors have 
speculated that spatial repellent products could hold distinct 
advantages over more traditional vector control tools such as 
IRS and LLINs.7-11 One key advantage of SR over IRS/ 
LLINs is the ability to create a space with reduced mosquito 
density without the requirement of the mosquitoes contacting 
a treated surface. In other words, protection is afforded at a
* Address correspondence to Din Syafruddin, Eijkman Institute for 
Molecular Biology, Jalan Diponegoro 69, Jakarta 10430, Indonesia. 
E-mail: din@eijkman.go.id
distance and can occur continuously during daytime, early 
evening, and night—a particular benefit when considering 
varied anopheline biting patterns and at-risk population life­
styles. Of importance, there is a reduced probability of creating 
a survival advantage with either behavioral or physiological 
resistance to the agent inducing this effect.4
Spatial repellency as a means of prevention was considered 
more than 60 years ago but never seriously pursued. Develop­
ment algorithms for chemicals aimed against mosquitoes have 
focused upon mortality effects for setting thresholds of effi­
cacy, and, indeed, SR properties were considered disadvanta­
geous (compromising contact and mortality). Agents of SR as 
effective tools of malaria prevention remain essentially an 
unexplored chemical universe. Spatial repellency has nonethe­
less been well documented under experimental conditions.12' 16 
Adopting SR as a broad prevention strategy, however, requires 
more practical demonstrations of impact. The current study 
aimed to provide limited proof-of-concept evidence of SR- 
mediated reduction of malaria transmission in communities 
naturally exposed to the pathogen.
MATERIALS AND METHODS
Ethics statement. Ethical review and approval for this study 
was granted by the Ethics Committee (EC) of the Faculty of 
Medicine, Hasanuddin University and endorsed by the Eijkman 
Institute Research Ethics Committee, Jakarta, Indonesia. 
Informed consent was obtained by subjects following EC 
guidelines to include descriptions of the study risks, benefits, 
and procedures of radical cure and follow-up. All adverse 
events were captured during participant follow-up and 
reported to monitoring authorities after approved protocol.
Study site. The study was conducted in Southwest Sumba 
District, East Nusa Tenggara Province, Indonesia (Figure 1). 
The 382,268 residents of the district live in 94 villages. Cross- 
sectional surveys during wet and dry seasons at 45 sites in this 
district during 2007 indicated a seasonal pattern of hypo- 
to meso-endemic malaria transmission with prevalence of
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F ig u r e  1. Map of the study site (box) in the Southwest Sumba District and its location in the Indonesian archipelago (map not to scale). 
The District is located in the western part of Sumba Island (insert).
microscopically patent parasitemia ranging from 0% to 34%, 
with a median prevalence of 6%.17 The higher prevalence 
among these sampled sites is typically nearer the coast. Two 
such villages, Umbungedo and Wainyapu, with populations of 
2,678 and 2,576, respectively, served as the study sites. The 
prevalence of parasitemia in two mass blood surveys of the 
villages employing random sampling (50% of residents) was 
3.5% at Umbungedo and 24.7% at Wainyapu 3 and 10 months 
before the start of the intervention, respectively (Table 1). 
Although very little is known of the malaria vector bionomics 
in this area, one entomologic survey documented 11 species of 
anophelines occurring in this district: Anopheles sundaicus, 
Anopheles subpictus, Anopheles barbirostris, Anopheles 
hyrcanus, Anopheles aconitus, Anopheles flavirostris, Anopheles
T a b l e  1
Parasitologic baseline data of the study sites
Study location*
Number of samples 
collected in MBSt
Number of malaria 
positive cases SPR* (%)
Wl 180 57 31.7
W2 197 75 38.1
Ul 404 23 5.7
U2 449 15 3.3
*A total of four clusters were designated from two study villages; Wainyapu 1 (Wl), 
Wainyapu 2 (W2); Umbungedo 1 (U l), Umbegedo 2 (U2).
tM ass blood survey (MBS) conducted at 3 (U l and U2) and 10 months (Wl and W2) 
before intervention.
$ Slide positivity rate (SPR).
annularis, Anopheles maculatus, Anopheles tessellatus, 
Anopheles vagus, and Anopheles kochi, 18 These species 
occurred in relative abundance in accordance with their 
respective preferred habitats including coastal marshes and 
ponds, seasonal rice paddies, and forested hillsides. This 
setting is typical for many rural malaria-endemic areas in 
Indonesia, particularly high risk coastal zones.19 Residents of 
the study village work principally in agriculture, have no pub­
lic electricity or water, and reside overwhelmingly in tradi­
tional large thatch and bamboo homes averaging 80 m3 that 
offer little protection from mosquito entry. Thus, the site main­
tained relatively high malaria attack rates, primarily from 
An. sundaicus, which is typically found in coastal settings 
and has been confirmed to be an important vector species in 
the region.
Sample size. Previous malaria incidence rate surveys in 
other locations of Indonesia20 were used to predict a likely 
malaria attack rate in the current study villages ranging between 
0.2 and 2.0 infections/person-year. Assuming a 6-month expo­
sure risk period (i.e., approximate typical high malaria trans­
mission period at this location), it was anticipated that 
between 0.1 and 1.0 infections would occur per person or that 
the proportion of subjects becoming infected during the inter­
vention would fall between 10% and 100%. Sample size 
requirements were estimated based on the ability to detect a 
difference between treatment arms with standard alpha = 0.05
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and beta = 0.80, and powered to permit detection of a 25% 
intervention effect size with a relatively low attack rate 
( 2 0 % ) . 21-23
Study design. The study was a split cluster-randomized, 
double-blinded, and placebo-controlled longitudinal cohort 
design. The selection of cluster randomization was based on 
the distribution and movement of mosquitoes and chemicals 
eliciting SR; both of these could move from house to house 
within a village, therefore the spatial unit of potential impact 
was the cluster. The study was designed and powered to 
develop evidence of sufficient efficacy for SR to justify a 
much larger and adequately statistically powered cluster ran­
domized SR trial. The SR agent used in this study was 
metofluthrin, a commonly used compound in commercially 
available mosquito coils, and with demonstrated repellency 
effects against anopheline mosquitoes. 7-9
After baseline entomologic and parasitologic (Table 1) site 
surveys, households from both Wainyapu and Umbungedo 
villages were stratified into four clusters: Wainyapu 1 (Wl, 
pop. 502, houses 92) and Wainyapu 2 (W2, pop. 523, houses 
102), Umbungedo 1 (Ul, pop. 596, houses 93) and 
Umbungedo 2 (U2, pop. 651, houses 98) (Figure 2). The areas 
of each cluster were chosen with the intent of roughly dividing 
each village into equal halves. The clusters in each village 
were randomized to receive either treatment mosquito coils 
(containing 0.00975% metofluthrin) or placebo mosquito 
coils (containing inert ingredients only and no metofluthrin). 
The randomization process ensured that each village had both 
active and placebo treatments. The study administrator
obtained a list of lot manufacturing codes from the coil man­
ufacturer (S.C. Johnson Co., Ho Chi Minh, Vietnam) that 
identified coils as either active or placebo. The administrator 
then assigned a code specific to each home and labeled pack­
ages of coils corresponding to cluster assignment to active or 
placebo coil treatment. These assignments were kept in a 
sealed envelope in a secure location within the managing 
center of the research program (Jakarta). Thus, the investiga­
tors, research team, study subjects, and residents were blinded 
as to which cluster received active versus placebo coils until 
after completion of the study.
The primary endpoint for estimating the protective efficacy 
of this spatial repellent intervention was malaria incidence 
among 45 sentinel subjects resident (study participants) in 
each of the four clusters, i.e., 180 subjects in all. These sentinel 
subjects, called the attack rate cohort, were all men living 
in separate households, which received a directly observed, 
presumptive radical cure to clear them of any standing (pat­
ent, sub-patent, or latent) malaria infections of blood and 
liver. Weekly blood film exams were conducted for the dura­
tion of the study. This provided an essential analytical advan­
tage, i.e., all new infections occurring in these subjects could 
only have originated from mosquito-borne sporozoite inocu­
lation rather than recrudescence or relapse stemming from 
infection before intervention.
Enrollment for attack rate cohort and radical cure. Men 18
to 60 years of age representing single households among study 
clusters were provided the opportunity to enroll in the study. 
Following informed consent, screening consisted of physical
Kilometers
F igure 2. Map of the household clusters in the Umbungedo and Wainyapu villages. Four clusters: U l, U2, Wl, and W2 (grayed) were selected, 
each consisted of ca. 100 households and 500 people each.
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examination by a study physician and a qualitative test for 
G6PD deficiency (Trinity Biotech qualitative G6PD 
assayTM, ref 345-UV, Trinity Biotech, St. Louis, MO). In 
addition to G6PD normal status, eligibility requirements 
included a bodyweight > 40 kg, hemoglobin > 8 mg/dL 
(Hb201+, HemoCue AB, Angelholm, Sweden) no significant 
chronic illness, participant must sleep in the village > 90% of 
nights, and no plans for extended travel during the study. A 
total of 180 subjects (75 men per village plus an additional 
30 to account for anticipated losses to follow-up) were treated 
using a fixed combination formulation of dihydroartemisinin 
(DHA) 6.4 mg/kg and piperaquine (P) 51.2 mg/kg body 
weight for 3 days (Arterakin™, PHARBACO Central Phar­
maceutical JSC No. 1, Hanoi, Vietnam) and 0.5 mg/kg body 
weight primaquine (Kimia Farma, Semarang, Indonesia) for 
the 28 days immediately before starting the coil intervention. 
The DHA+P combination is currently the first-line antimalarial 
drug for malaria treatment in Indonesia.24 Although primaquine 
treatment policy in Indonesia calls for 0.25 mg/kg for 14 days, 
we administered 0.5 mg/kg for 28 days to ensure a greater 
probability of complete efficacy against relapse, and knew this 
dose to be safe and well tolerated in Indonesians.25,26 The same 
dose of primaquine for 14 days and administered with DHA-P 
was 98% efficacious in Indonesian soldiers infected in Papua.27 
New malaria infections among the 180 participants were mon­
itored with weekly microscopic examination of Giemsa-stained 
blood films at project-dedicated field clinics and laboratories 
located in each of the two study villages.28 Participants found 
positive for malaria parasites were immediately treated with 
DHA+P and removed from the study, thereby ending their 
contribution to person-time at risk of infection.
Experimental intervention. Immediately after completion 
of radical cure in the attack rate cohort, intervention was simul­
taneously initiated in all households. Blank (metofluthrin-free) 
or 0.00975% metofluthrin-treated coils of identical packaging 
and color were randomly assigned to houses using a 90:10 
distribution ratio of each treatment within a single study clus­
ter (Wl, W2, U l, and U2). The 90:10 distribution ratio effec­
tively provided a 90% coverage rate for treatments within 
clusters, and the minority treatment could reveal trends in 
village level effects (but without the power to ascertain quan­
titative effects). All houses were provided four coils each 
night by project personnel and were ignited at 1800 h. One 
coil was positioned at each of four corners of the house (vir­
tually all were single room dwellings) and placed on standard 
metal stands fixed within 20 x 20 x 6 cm metal pans. The 
pans facilitated stabilization of the coil on the bamboo floor­
ing and provided protection to the coil from excessive wind 
currents resulting in more even burning. The -288,000 active 
and placebo coils used were manufactured by S.C. Johnson, 
Inc., to the specifications of this trial. They were designed to 
provide a 12-hour burn and homeowners were asked to 
relight coils if they burned out prematurely. Research team 
members regularly surveyed coil pans at randomly selected 
homes each morning to ascertain successful burn rates (i.e., 
cm length of coil remaining at dawn). They also routinely 
surveyed randomly selected homes for adverse health effects 
conceivably related to coil burning.
Entomologic parameters. Adult mosquito densities were 
measured using human-landing catches (HLC). Five sentinel 
houses within each study cluster were selected for sampling. 
Collections were conducted weekly from all sentinel houses
within a given village simultaneously. Sentinel houses were 
blindly selected to include two houses with metofluthrin 
active coils, two with blank coil treatments, and one house 
without coil intervention during the given sampling night. 
This ensured comparison between active and placebo and to 
“natural” conditions. The sentinel house without the coil was 
provided a blank coil (the lone exception to coil treatment 
blinding) on all nights other than when the HLC was being 
performed. Teams of two collectors were assigned per house, 
one positioned indoors at the center of the house and one 
located outside on the verandah ~1 m from the exterior wall. 
Collectors removed all mosquitoes landing on their exposed 
lower legs using a mouth aspirator. Collections were con­
ducted from 1800 to 0600 h for 50 min every hour. Collectors 
rotated the indoor and outdoor position every hour. Samples 
were placed into individual holding containers labeled by 
hour of collection, unique house code (that corresponded to 
treatment), and collection location (indoor or outside). Mos­
quitoes were immediately killed by chloroform vapor in the 
field and identified to species (or species complex) using mor­
phological characteristics.29 All specimens were transported 
to the project laboratory upon completion of the 12 h HLC 
and a representative random sample of anophelines were dis­
sected for parity and scored as either gravid/parous or nullip- 
arous.’0 Partial (head-thorax) and whole anopheline specimens 
were placed singly into individual vials and stored with 
silica gel desiccant until further processing at the Eijkman 
Institute for Molecular Biology, Jakarta, for detection of 
malaria sporozoites and molecular-based species identification, 
where applicable.
Mosquito samples were evaluated for Plasmodium spp. 
infection using a circumsporozoite protein (CSP) enzyme- 
linked immunosorbent assay (ELISA)31 and polymerase 
chain reaction (PCR) methodologies32 to derive correspond­
ing malaria sporozoite rates by parasite (P. falciparum, Plas­
modium vivax, Plasmodium malariae, and Plasmodium ovale) 
and vector species. Together with time-adjusted HLC densities 
(anophelines/person-night), matched sporozoite rates were 
used to derive the entomological inoculation rates (EIRs) for 
each treatment arm.33
Indoor and outdoor resting collections were conducted 
weekly from the five sentinel houses used for HLC in each 
cluster. During daylight early morning hours, a team of three 
persons per house systematically sampled each house for a 
total of 60 min from four locations (inside, under the house, 
on the outside house veranda, and within the peridomestic 
area (10 m circumference from the house). Sampling was 
conducted using a modified Prokopack handheld aspirator.^4 
Additionally, to capture blood-fed mosquitoes, a wooden 
“resting box” fitted with a black cloth lining was placed 
outdoors of each sampled house within a standard 10 m 
distance from the exterior walls and in a location with high 
probability for vector refuge. All captured resting mosqui­
toes were placed in labeled containers and returned to 
the laboratory for identification and processing for blood- 
meal analysis.35
Statistical analyses. The impact of SR on risk of malaria was 
estimated by measuring incidence density of new cases of 
malaria among cohorts of 45 sentinel subject men in each of 
the study clusters. The primary estimate of impact was deter­
mined by calculating the protective efficacy of the interven­
tion based on incidence density (number of infections per
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person year at risk) of new parasitemias among the malaria 
attack cohort as follows22,23,36:
^ ([Incidence]PLACEB0 -  [Incidence]ACTIVE) 
j  [Incidence]PLACEB0^  x 100 = %Efficacy.
Risk rate (RR) was calculated from the ratio of overall 
incidence rate in the active and placebo groups. To adjust for 
possible clustering effect, geometric mean of the cluster inci­
dence rate (RRGM) was used to estimate of intervention 
effect when the incidence rates in each group were highly 
skewed.22 One approach to cumulative incidence analysis 
involved direct adjustment of the j 2 statistic, which depends 
on clustering effects for each intervention group.
The secondary endpoint, anopheline vector human landing 
rates during the study period, was analyzed by the nonpara- 
metric Wilcoxon rank-sum statistical test to compare cumula­
tive indoor catch densities between treatment arms by week 
of collection with 2 x 2  contingency tables used to generate
and compare risk rates over time. The EIR by matched 
time and place were calculated combining the mean human­
landing density with proportion of anophelines deemed 
“infective” with sporozoites.33 All hourly HLC rates were 
adjusted for 60 min before calculating the EIR.
RESULTS
Intervention. The morning observation of coil remnants 
showed high success “burn” rates. Of the 263,520 coils observed 
during the intervention period, 97.82% had no coil material 
remaining the following morning. Of the 2.18% coils that failed, 
the average coil remnant was 34 cm (95% confidence interval 
[Cl]: 26.7^12.2) of a total starting coil length of 125 cm. There 
was no instance of all four coils failing in the same house on the 
same night. Full exposure to coil smoke/active ingredient 
occurred during the 6 months of intervention. No coil-related 
serious adverse events were reported, and reported adverse 
event rates did not differ between active and placebo coil 
homes. No burn injuries occurred, nor did any home fire inci­
dents, and no household requested cessation of coil burning.
F igure 3. Flowchart of the screening and enrollment of study volunteers. Two hundred and thirty-one subjects were screened for G6PD 
deficiency and 180 consented to be enrolled and provided radical cure for malaria of which 170 completed the treatment and subsequently 
followed up for 6 months during the intervention.
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Malaria attack and protective efficacy. Figure 3 summarizes 
screening, enrollment, and follow-up of the 180 subjects of the 
incidence density cohorts among the four clusters. Almost all 
subjects completed radical cure and the 6 months of follow-up. 
Analytical results for incidence rate, cumulative incidence 
analysis, and clustering effect adjustment are presented in 
Table 2. A total of 61 malaria infections within 1,468 person- 
weeks at risk were seen in participants whose households 
were given blank coils (clusters W2 and Ul), with a calculated 
incidence density of 2.184 infections/person-year. In contrast, 
31 malaria attacks occurred among participants in metofluthrin 
coil-treated households among the 1,540 person-weeks at 
risk resulting in a calculated 1.04 infections/person-year. The 
protective efficacy of metofluthrin coils was thus estimated 
at 51.6% (95% Cl 25.4-68.6%). The relative risk (RR [95% 
Cl] of infection among active versus placebo coils was 0.48 
[0.31-0.75]).
Because Wainyapu and Umbungedo were less similar than 
anticipated, a second analysis based on cumulative incidence 
was performed to account for possible clustering effects; the 
RR became 0.65 (0.09^1.8), i.e., statistically insignificant and 
protective efficacy was reduced 46.8% (95% Cl 27.3-61%). 
The RR without clustering effects was 0.53 (0.39-0.73), but a 
cluster-specific adjusted %2 value was 2.356 (P = 0.124).
Anopheline landing rates. A total of 26 weeks of HLC were 
performed within each cluster during the intervention trial. 
From these collections, An. sundaicus species E was the pre­
dominant anopheline captured representing 86.6% (N  = 1,603) 
and 82.2% (N  = 74) of the total collections from Wainyapu 
and Umbungedo villages, respectively. Distribution of other 
anopheline species included: 11.2% (264) An. subpictus sensu 
lato, 0.3% (7) An. indefinitus, 0.2% (5) An. vagus, 0.89% (21) 
An. barbirostris, 0.04% (1) An. annularis and An. maculatus, 
0.2% (5) An. aconitus, 0.08% (2) An. kochi and 0.2% (5) 
An. tessellatus. The majority of An. sundaicus were collected 
outdoors to give an indoor to outdoor biting ratio of 1:1.74.
A total of 2,345 anophelines were processed for CSP detec­
tion using ELISA and PCR analyses. Of these, only
An. sundaicus were detected CSP positive (15 of 1,825) and 
only from the W1 and W2 (Wainyapu) clusters. Molecular 
identification examining the mtDNA of samples of 
An. sundaicus found all specimens assayed to be An. sundaicus 
E, as yet an undescribed formal species in the complex.37
The cumulative indoor An. sundaicus landing rates from 
Wainyapu and Umbungedo villages are shown in Figure 4. 
Overall, there was a significantly reduced landing density 
from collections performed at sentinel households containing 
metofluthrin coils as compared with those assigned to blanks 
(P = 0.0342). This difference resulted in a combined 32.9% 
reduction in An. sundaicus attack rate on collectors at sentinel 
households with active coils compared with blank houses in 
Wainyapu (W1 and W2) (P = 0.04388). Similar attack rate ratios 
could not be performed in the Umbungedo clusters as overall 
HLC densities of An. sundaicus mosquitoes were too low.
Age-grading. The proportion of sampled females catego­
rized as “older,” combining parous and gravid (those with 
developing ovarian follicles as evidence of recent blood 
meal), and those “younger” as nulliparous and recently 
emerged were compared between the four sub-cluster sentinel 
HLC sites. Sufficient HLC numbers were only present in W1 
and W2 areas to allow comparisons. Overall older: younger 
ratio between “active,” “blank,” and “no coil” homes were 
not statistically different over the entire study, therefore indi­
cating sites remained comparable regarding age structure 
throughout the sampling.
Adult resting collections. Despite many hours of effort 
each week, the total number of anophelines captured indoors 
and outside of the sentinel houses was extremely low, only 
88 (0.17 Anopheles per house sampling week) were recorded 
of which 60% were collected indoors. The remaining 35 mos­
quitoes were found either underneath the house, on the 
veranda area, or in the immediate surroundings. Collection 
attempts in outdoor locations produced only 10% of all 
mosquitoes captured. The predominant species (75%) was 
An. sundaicus, 64% of which were found indoors. This is 
further evidence confirming its status as the primary malaria
Table 2
Incidence rate and cumulative incidence of malaria in clusters treated with metofluthrin (active)- and placebo coils
Wainyapu Umbungedo All villages
Cluster 1 (W l) Cluster 2 (W2) Cluster 3 (U l) Cluster 4 (U2) Cluster 1 + 4 Cluster 2 + 3
90% Active+ 
10% placebo
10% Active+ 
90% placebo
10% Active+ 
90% placebo
90% Active+ 
10% placebo
Active
clusters
Placebo
clusters
Household active:placebo 108 114 115 108 216 229
(98:10) (11:103) (12:103) (98:10) (196:20) (23:206)
Population 368 523 596 633 1001 1119
Samples 42 44 43 41 83 87
Malaria incident 26 40 21 5 31 61
Incidence density 
Person-week 652 602 866 888 1540 1468
Incidence rate 0.040 0.066 0.024 0.006 0.020 0.042
Without clustering effect 
RR (95% Cl)
With clustering effect 
R R gm (95% Cl) 
Cumulative incidence 
Proportion of incidence 0.619 0.909 0.488 0.122
0.484 (0.314-0.746) 
0.652 (0.088-4.802) 
0.373
Without clustering effect
RR (95% Cl) 0.533 (0.390-0.727)
With clustering effect
Cluster-specific adjusted x2 (P-value) 2.356 (P = 0.124)
RR = rate ratio; Cl = confidence interval.
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Cumulative Attack in Wainyapu (W1+W2) 
Indoor Only
Cumulative Attack in Umbungedo (U1+U2) 
Indoor Only
- In d o o r -A .I
W e e k
— •In d o o r  - Placebo - In d o o r -A .I
W e e k
— Indoo r - Placebo
F igure 4. 
Both villages
Cumulative weekly indoor attack rates of Anopheles sundaicus, pooled by village cluster in Wainyapu and Umbungedo, respectively, 
showed significantly different indoor Anopheles biting densities between active and placebo houses during 26 weeks of observation.
vector in the study area. Anopheles subpictus s.l. represented 
the second most common species (17%). Only 22 (29%) of 
74 tested contained evidence of a blood meal, 77% were cap­
tured resting indoors. Human blood was only detected in four 
samples (three An. sundaicus), others included single or mixed 
dog, goat, pig, bovine, and avian (chicken) blood proteins.
DISCUSSION
This study focused on two primary challenges: 1) establish a 
proof-of-concept regarding spatial repellents for a reduction 
in malaria transmission and 2) determine what entomological 
measures might be predictive of an SR impact. Incident infec­
tion, pooled according to intervention treatment (i.e., active 
versus placebo coils), served as the indicator of transmission 
and the primary parasitological impact outcome. The two 
villages were selected with the assumption that clusters could 
be pooled but calculated incidence rates following interven­
tion indicated this would be inappropriate. For that reason we 
applied an additional statistical analysis to allow for possible 
cluster effects. The authors acknowledge that conventional 
cluster-randomized study designs typically incorporate more 
clusters to reconcile the intra-cluster variation; however, it is 
important to note this work was never intended to be a robust 
proof of concept, which necessarily will require multiple rep­
licates of each cluster.
The findings in this study offer preliminary evidence of 
reduced transmission in clusters of homes treated with a spa­
tial repellent product containing metofluthrin. Such evidence 
of human health impact is a fundamental and essential com­
ponent in the critical path of development of any vector con­
trol tool,38-41 especially new paradigms such as SR.4 If the 
crude estimate of protective efficacy shown here, about 52%, 
is verified in statistically robust cluster-randomized trials, this 
instrument of control would likely approximate that benefit 
associated with LLINs 42
It is important to note this study was not intended to assess 
a practical method of delivery of a spatial repellent product in 
malaria control. Using four coils per single-room home every 
night under direct supervision and monitoring is of course 
neither practical nor feasible as a long-term intervention prac­
tice. A flameless and passive means of distributing an active
ingredient vapor that elicits SR would offer far greater use. 
However, the burning coil system was deemed an expedient 
means of testing the concept of SR reduction of risk of 
malaria infection because this format provides a nearly con­
stant concentration of repellent chemical throughout the 
night (Johnson SC, personal communication). The multiple 
coils per home, direct supervision of use, and clustering to 
capture possible village protective effects were all deliberate 
means of maximizing protective efficacy as integral to proof 
of concept.
Analyses of HLCs indicated a significant reduction in vector 
landing rates of the primary malaria vector in the study area, 
An. sundaicus, in those houses that contained metofluthrin 
active coils compared with blank coils. As this was the primary 
attacking species and the only anopheline to be found positive 
for Plasmodium sporozoites, there is a high probability that the 
reduction in malaria incidence among study participants was 
directly associated with the reduction in human-vector contact 
by this species. For An. sundaicus in western Sumba, only HLC 
and sporozoite infections were found useful as correlates for 
coil effectiveness, i.e., significantly reducing indoor vector con­
tact with humans. Other monitoring such as longitudinal age 
determination (parity), indoor/outdoor vector resting collec­
tions, and blood meal analysis, proved to be imprecise 
measures of potential impact with this vector species and 
epidemiological setting.
The authors recognize that chemicals such as metofluthrin 
exert a number of actions on mosquitoes, which may ultimately 
result in a vector free space. These actions are dose-dependent 
and include vapor phase repellency (at concentrations below 
toxic thresholds) and vapor phase toxicity (at higher doses). 
Although the current protocol could not differentiate the con­
tribution of these two actions to the success of reduced HLC, 
we are confident that the concentration encountered in the 
house was well below the toxic level for metofluthrin based on 
air sampling conducted inside and outdoors of experimental 
huts using same dose metofluthrin coils4 Nevertheless, this 
remains a critical missing piece of the equation and will require 
a more detailed, integrated investigative approach involving 
other tools such as laboratory-based excito-repellency assays 
(e.g., HITSS) and field-based experimental huts (e.g., entry 
and exit traps).4
1086 SYAFRUDDIN AND OTHERS
The current study also begs the questions of mosquito 
diversion and village-level protective effects. The minority 
treatments within clusters (i.e., the 10 of the 90:10 randomiza­
tion in each cluster) were inadequately powered for observa­
tion of definitive findings. However, the cumulative incidence 
of malaria infection among homes receiving placebo and 
being surrounded by homes receiving active coils was similar 
to that among homes in clusters with a placebo majority.
Another possible weakness in this study is the potential 
confounding effect by variable risk of exposure among the 
few clusters used. In other words, the 52% protective efficacy 
could be less an effect of SR and more geographic variance in 
risk of infection that happened to align by chance with ran­
domized SR assignment. The more clusters examined, the less 
likely chance observations will confound intervention impact 
estimates. In this study we used a split-cluster design that 
renders only two clusters per treatment, thus resulting in a 
sample size of just two paired treatment clusters. Randomiza­
tion to placebo treatment at these two paired cluster sites 
need only have favored the more heavily malarious cluster 
twice in a row to explain the observed protective effects. 
However, such an explanation requires invoking a degree of 
heterogeneity in transmission dynamics between the clusters 
within the same villages that is unlikely to have occurred 
during this 26-week trial.
In conclusion, this study has added further evidence that a 
vector control strategy, which reduces mosquito attack rates 
without requiring direct vector contact on treated surfaces, 
can reduce malaria transmission in endemic settings.43 The 
results presented here have encouraged the substantial invest­
ment required to validate SR as a means of risk and harm 
reduction using larger cluster-randomized trials, as was done 
with insecticide-treated nets,38,44’ including the investigation 
of possible risk/infection diversion effects of SR.
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